|
FLCN expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.209600E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.998000E-04 |
| Normal-vs-Stage2 |
1.978310E-02 |
| Normal-vs-Stage3 |
5.950400E-04 |
| Normal-vs-Stage4 |
4.680000E-03 |
| Stage1-vs-Stage2 |
9.011000E-01 |
| Stage1-vs-Stage3 |
6.882800E-01 |
| Stage1-vs-Stage4 |
8.809200E-01 |
| Stage2-vs-Stage3 |
6.964400E-01 |
| Stage2-vs-Stage4 |
8.276000E-01 |
| Stage3-vs-Stage4 |
8.799400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.816240E-04 |
| Normal-vs-AfricanAmerican |
6.460300E-02 |
| Normal-vs-Asian |
1.605020E-01 |
| Caucasian-vs-AfricanAmerican |
6.198800E-01 |
| Caucasian-vs-Asian |
1.060970E-01 |
| AfricanAmerican-vs-Asian |
5.387000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.215050E-04 |
| Normal-vs-Female |
8.197600E-04 |
| Male-vs-Female |
2.194600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.095500E-03 |
| Normal-vs-Age(41-60Yrs) |
3.372900E-04 |
| Normal-vs-Age(61-80Yrs) |
2.640000E-04 |
| Normal-vs-Age(81-100Yrs) |
8.54509999981268E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.264000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.961370E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.786000E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.932400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.517400E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.604400E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.958200E-01 |
| Classical-VS-Follicular |
1.560380E-01 |
| Classical-VS-Other |
2.645200E-01 |
| Classical-VS-Normal |
1.075130E-03 |
| Tall-VS-Follicular |
2.273600E-01 |
| Tall-VS-Other |
1.969960E-01 |
| Tall-VS-Normal |
2.389900E-02 |
| Follicular-VS-Other |
6.922000E-01 |
| Follicular-VS-Normal |
1.216140E-03 |
| Other-VS-Normal |
3.671900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.361400E-04 |
| Normal-vs-N1 |
1.157930E-02 |
| N0-vs-N1 |
6.404800E-01 |
|
|
